Not directly. Testosterone replacement therapy is not a weight-loss treatment and is not approved for one. In men with clinically low testosterone, research has associated restoring testosterone with changes in body composition — a shift toward less fat mass and more lean muscle — but the number on the scale may not move much, because muscle is denser than fat. Any effect is gradual, modest, and specific to men who are genuinely deficient.

Testosterone influences how the body builds muscle and stores fat. The testosterone PDPs describe therapy as supporting "lean muscle mass, strength, bone density, and healthier fat distribution over time," with effects on muscle synthesis, fat distribution and insulin sensitivity appearing gradually. That is a body-composition shift, studied in men with low testosterone — not a promise of weight loss, and not the same thing as a fat-burning drug.

There is no evidence that adding testosterone helps men whose levels are already normal, and doing so carries risk without a clinical reason. TRT is intended for men with clinically low testosterone confirmed by blood testing plus symptoms. A licensed clinician reviews your labs and history and will tell you if your testosterone is not the issue.

No. Testosterone replacement therapy is FDA-approved only for diagnosed hypogonadism (clinically low testosterone). Using it for weight loss, general wellness or "anti-aging" is off-label. Healthspan does not promise weight-loss outcomes from TRT — a clinician determines whether testosterone therapy is medically appropriate based on your labs and symptoms.

If losing weight is the primary goal, the studied path is metabolic care, not testosterone. Approaches like GLP-1 medication, metformin and lifestyle change are the interventions designed and tested for weight loss and blood-sugar control. Healthspan runs metabolic-health care for exactly that, and the 2-minute assessment can point you to the right track — hormones, metabolism, or both.

Comprehensive lab testing is required before starting testosterone therapy and continues throughout care — Healthspan tracks 70+ biomarkers across nine biological systems, including sex hormones, blood counts, prostate markers, metabolic function and cardiovascular risk, and hematocrit is routinely monitored. Testosterone is delivered as a twice-weekly subcutaneous injection of testosterone cypionate or a daily transdermal gel, with dosing individualized and adjusted over time. It is not recommended for men actively trying to conceive, as it can suppress fertility.